The Biden-Harris Administration announced crucial measures aimed at strengthening the nation’s medical supply chain resilience. The Department of Health and Human Services (HHS) detailed that President Biden plans to issue a Presidential Determination under Title III of the Defense Production Act to expand HHS authorities, allowing investment in domestic manufacturing of essential medicines and medical countermeasures. HHS emphasized the importance… (Colocho, November 29, 2023) #Generic Drugs, #Medical Devices, #Prevention, #Public Health